Cargando…

Development and Validation of a Multivariable Lung Cancer Risk Prediction Model That Includes Low-Dose Computed Tomography Screening Results: A Secondary Analysis of Data From the National Lung Screening Trial

IMPORTANCE: Low-dose computed tomography lung cancer screening is most effective when applied to high-risk individuals. OBJECTIVES: To develop and validate a risk prediction model that incorporates low-dose computed tomography screening results. DESIGN, SETTING, AND PARTICIPANTS: A logistic regressi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tammemägi, Martin C., ten Haaf, Kevin, Toumazis, Iakovos, Kong, Chung Yin, Han, Summer S., Jeon, Jihyoun, Commins, John, Riley, Thomas, Meza, Rafael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2019
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6484623/ https://www.ncbi.nlm.nih.gov/pubmed/30821827 http://dx.doi.org/10.1001/jamanetworkopen.2019.0204

Ejemplares similares

A Comparative Modeling Analysis of Risk-Based Lung Cancer Screening Strategies
por: ten Haaf, Kevin, et al.
Publicado: (2019)

Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study
por: ten Haaf, Kevin, et al.
Publicado: (2017)

Correction: Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study
por: ten Haaf, Kevin, et al.
Publicado: (2020)

Comparing Benefits from Many Possible Computed Tomography Lung Cancer Screening Programs: Extrapolating from the National Lung Screening Trial Using Comparative Modeling
por: McMahon, Pamela M., et al.
Publicado: (2014)

Cost-Effectiveness Analysis of Lung Cancer Screening Accounting for the Effect of Indeterminate Findings
por: Toumazis, Iakovos, et al.
Publicado: (2019)

A Cost-Effectiveness Analysis of Lung Cancer Screening With Low-Dose Computed Tomography and a Diagnostic Biomarker
por: Toumazis, Iakovos, et al.
Publicado: (2021)

Risk Model–Based Lung Cancer Screening and Racial and Ethnic Disparities in the US
por: Choi, Eunji, et al.
Publicado: (2023)

Impact of U.S. Preventive Services Task Force lung cancer screening update on drivers of disparities in screening eligibility
por: Maki, Kristin G., et al.
Publicado: (2022)

Prevalence of Lung Cancer Screening Among Eligible Adults in 4 US States in 2021
por: Maki, Kristin G., et al.
Publicado: (2023)

Personalising lung cancer screening: An overview of risk‐stratification opportunities and challenges
por: ten Haaf, Kevin, et al.
Publicado: (2021)

Evaluation of benefits and harms of adaptive screening schedules for lung cancer: A microsimulation study
por: Cao, Pianpian, et al.
Publicado: (2022)

Evaluation of the Lung Cancer Risks at Which to Screen Ever- and Never-Smokers: Screening Rules Applied to the PLCO and NLST Cohorts
por: Tammemägi, Martin C., et al.
Publicado: (2014)

Racial and Ethnic Disparities in Lung Cancer Screening by the 2021 USPSTF Guidelines Versus Risk-Based Criteria: The Multiethnic Cohort Study
por: Aredo, Jacqueline V, et al.
Publicado: (2022)

Contemporary issues in the implementation of lung cancer screening
por: Lam, Stephen, et al.
Publicado: (2021)

Performance and Cost-Effectiveness of Computed Tomography Lung Cancer Screening Scenarios in a Population-Based Setting: A Microsimulation Modeling Analysis in Ontario, Canada
por: ten Haaf, Kevin, et al.
Publicado: (2017)

Factors Associated With Small Aggressive Non–Small Cell Lung Cancers in the National Lung Screening Trial: A Validation Study
por: Warkentin, Matthew T, et al.
Publicado: (2018)

Implementation of lung cancer screening: what are the main issues?
por: van der Aalst, Carlijn M., et al.
Publicado: (2021)

Personalised Lung Cancer Screening (PLuS) study to assess the importance of coexisting chronic conditions to clinical practice and policy: protocol for a multicentre observational study
por: Braithwaite, Dejana, et al.
Publicado: (2022)

Associations Between E-cigarette Use and E-cigarette Flavors With Cigarette Smoking Quit Attempts and Quit Success: Evidence From a U.S. Large, Nationally Representative 2018–2019 Survey
por: Mok, Yoonseo, et al.
Publicado: (2022)

Evaluation of a Low-Dose Computed Tomography Lung Cancer Screening Program in Henan, China
por: Guo, Lan-Wei, et al.
Publicado: (2020)

Racial Disparities in Lung Cancer Screening Among Veterans, 2013 to 2021
por: Navuluri, Neelima, et al.
Publicado: (2023)

Lung Cancer Screening in Individuals With and Without Lung-Related Comorbidities
por: Metwally, Eman M., et al.
Publicado: (2022)

Cost-Effectiveness of a Telephone-Based Smoking Cessation Randomized Trial in the Lung Cancer Screening Setting
por: Cao, Pianpian, et al.
Publicado: (2022)

Cost-effectiveness of Low-Dose Computed Tomography With a Plasma-Based Biomarker for Lung Cancer Screening in China
por: Zhao, Zixuan, et al.
Publicado: (2022)

Factors Associated With Nonadherence to Lung Cancer Screening Across Multiple Screening Time Points
por: Lin, Yannan, et al.
Publicado: (2023)

Estimated US Cancer Deaths Prevented With Increased Use of Lung, Colorectal, Breast, and Cervical Cancer Screening
por: Knudsen, Amy B., et al.
Publicado: (2023)

Treatment capacity required for full‐scale implementation of lung cancer screening in the United States
por: Blom, Erik F., et al.
Publicado: (2019)

Lung Cancer Incidence Trends by Gender, Race and Histology in the United States, 1973–2010
por: Meza, Rafael, et al.
Publicado: (2015)

Lung Cancer Screening by Race and Ethnicity in an Integrated Health System in Hawaii
por: Oshiro, Caryn E. S., et al.
Publicado: (2022)

Assessment of Uptake Appropriateness of Computed Tomography for Lung Cancer Screening According to Patients Meeting Eligibility Criteria of the US Preventive Services Task Force
por: Liu, Yu, et al.
Publicado: (2022)

Estimated Prevalence of Smoking and Smoking-Attributable Mortality Associated With Graphic Health Warnings on Cigarette Packages in the US From 2022 to 2100
por: Tam, Jamie, et al.
Publicado: (2021)

Analysis of Eligibility for Lung Cancer Screening by Race After 2021 Changes to US Preventive Services Task Force Screening Guidelines
por: Pinheiro, Laura C., et al.
Publicado: (2022)

Evaluation of Lung Cancer Risk Among Persons Undergoing Screening or Guideline-Concordant Monitoring of Lung Nodules in the Mississippi Delta
por: Osarogiagbon, Raymond U., et al.
Publicado: (2023)

Evaluation of the Informational Content and Readability of US Lung Cancer Screening Program Websites
por: Gagne, Staci M., et al.
Publicado: (2020)

Association of Inclusion of More Black Individuals in Lung Cancer Screening With Reduced Mortality
por: Prosper, Ashley E., et al.
Publicado: (2021)

Patterns and Factors Associated With Adherence to Lung Cancer Screening in Diverse Practice Settings
por: Sakoda, Lori C., et al.
Publicado: (2021)

Methods for Using Race and Ethnicity in Prediction Models for Lung Cancer Screening Eligibility
por: Landy, Rebecca, et al.
Publicado: (2023)

Recommendations for Implementing Lung Cancer Screening with Low-Dose Computed Tomography in Europe
por: Veronesi, Giulia, et al.
Publicado: (2020)

The Impact of Current Tobacco Product Use Definitions on Estimates of Transitions Between Cigarette and ENDS Use
por: Brouwer, Andrew F, et al.
Publicado: (2022)

Patient Adherence to Screening for Lung Cancer in the US: A Systematic Review and Meta-analysis
por: Lopez-Olivo, Maria A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8vclsj4f3maum5kcl9vc0odib7